FAB-KLEAR investigates lucerastat as a potential disease-modifying therapy targeting the kidney manifestations of Fabry disease. Nxera will contribute to ...
American Hospital Dubai ("AHD"), one of the Middle East's premier private healthcare providers and a member of the Mayo Clinic Care Network, and HEI Global...
BioNTech enters a clinical trial collaboration with Gilead Sciences with the aim of improving outcomes in patients with PD-L1 low or negative triple-nega...
Okomera reaches a key milestone in its industrial rollout with the first commercial installation of its integrated platform, combining hardware, softwa...
Ambrose Healthcare, a rare disease specialist, has acquired 100% of the shares of AM-Pharma. Under the terms of the agreement, AM-Pharma's shareholders are...
Collaboration will combine Zealand Pharma’s expertise in metabolic health with Generate’s proprietary generative AI platform to create multis...
GCCL, a South Korea-based leading global clinical trial central laboratory represented by CEO Kwan-goo Cho, announced that it signed a Memorandum of Unders...
Andelyn Biosciences (“Andelyn”), a leading US-based patient-focused cell and gene therapy Contract Development and Manufacturing Organization (...
Independent European source of exatecan will expand choice and strengthen supply resilience for ADC developers Gram-scale material available, with...
Strategic collaboration combines Italfarmaco’s leadership in HDAC biology and therapeutic development with VeriSIM Life’s Mechanistic AI dr...
CSL and Alentis Therapeutics announced they have entered into an exclusive global collaboration agreement to co-develop and co-promote lixudebart, which ha...
Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturin...
Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/NYSE: AZN) have entered into a clinical trial collaboration agreement with Summit Therapeutics Inc. (Na...
Curaleaf International, part of Curaleaf Holdings, Inc. (TSX: CURA) in partnership with Jupiter Research LLC, announced that its Que Medical Inhalation Dev...
© 2026 Biopharma Boardroom. All Rights Reserved.
